Evidence map›Paper›PMID 40913209›Full record

ArticleRadiological physics and technology2025

Margin for compensating displacement of adrenal gland metastasis and fiducial marker along with respiratory phase in real-time motion-tracking radiation therapy.

Yuki Aoyama, Tetsuya Tomida, Susumu Nagata, Noriaki Muramatsu, Ryosei Nakada, Hideyuki Harada

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuki AoyamaRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan. y.aoyama@scchr.jp.ORCID http://orcid.org/0000-0002-7477-7803
Tetsuya TomidaRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.
Susumu NagataRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.
Noriaki MuramatsuRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.
Ryosei NakadaRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.
Hideyuki HaradaRadiation and Proton Therapy Center, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-Cho, Shizuoka, 411-8777, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In therapy with Synchrony® mounted on Radixact®, the fiducial marker (FM) and adrenal gland metastasis, which shift with respiratory phase, require margin compensation for high-dose prescriptions. Although compensation is critical, no studies have examined the margin to compensate for the respiratory phase shift. Therefore, we aimed to suggest the compensating margin for the FM and adrenal metastasis shift along with respiratory phase. We used images from four-dimensional computed tomography (4DCT) taken twice and gated CT taken once before therapy initiation with available contour data for FM and adrenal gland metastasis in each image. The distance between the FM and the center of the gross tumor volume (GTV) in each image of a ten-set 4DCT was defined as the correlating association, and a relative cumulative frequency distribution was created based on it. The values of the margins compensating for respiratory displacement were obtained from the relative cumulative frequency distribution in the right-left/posterior-anterior/superior-inferior (S-I) directions. In cases wherein the FM was placed inside the GTV, the margin values decreased in the S-I direction.

Indexed as

Adrenal Gland NeoplasmsFiducial MarkersRadiotherapy, Image-GuidedRespirationFour-Dimensional Computed TomographyHumansMaleMovementTime FactorsAdrenal gland metastasesFiducial markerMargin settingRespiratory managementStereotactic body radiation therapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.